About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 195367, 12 pages
http://dx.doi.org/10.1155/2012/195367
Research Article

Chronic Administration of Oil Palm (Elaeis guineensis) Leaves Extract Attenuates Hyperglycaemic-Induced Oxidative Stress and Improves Renal Histopathology and Function in Experimental Diabetes

1Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia
3Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
4Department of Anatomy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Received 6 August 2012; Accepted 17 October 2012

Academic Editor: Shrikant Anant

Copyright © 2012 Varatharajan Rajavel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. E. Mogensen, C. K. Christensen, and E. Vittinghus, “The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy,” Diabetes, vol. 32, supplement 2, pp. 64–78, 1983. View at Scopus
  2. S. Dronavalli, I. Duka, and G. L. Bakris, “The pathogenesis of diabetic nephropathy,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 8, pp. 444–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Shamoon, H. Duffy, N. Fleischer et al., “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Turner, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” The Lancet, vol. 352, no. 9131, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Ohkubo, H. Kishikawa, E. Araki et al., “Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study,” Diabetes Research and Clinical Practice, vol. 28, no. 2, pp. 103–117, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. T. H. Hostetter, “Hypertrophy and hyperfunction of the diabetic kidney,” The Journal of Clinical Investigation, vol. 107, no. 2, pp. 161–162, 2001. View at Scopus
  7. J. F. Navarro-González and C. Mora-Fernández, “The role of inflammatory cytokines in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 433–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Nishikawa, D. Edelstein, X. L. Du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Brownlee, “Biochemistry and molecular cell biology of diabetic complications,” Nature, vol. 414, no. 6865, pp. 813–820, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Forbes, M. T. Coughlan, and M. E. Cooper, “Oxidative stress as a major culprit in kidney disease in diabetes,” Diabetes, vol. 57, no. 6, pp. 1446–1454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Eun, Y. S. Ji, Z. Jiang et al., “Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney,” Kidney International, vol. 67, no. 5, pp. 1762–1771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Halliwell, “Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment,” Drugs and Aging, vol. 18, no. 9, pp. 685–716, 2001. View at Scopus
  14. H. B. Lee, M. R. Yu, Y. Yang, Z. Jiang, and H. Ha, “Reactive oxygen species-regulated signaling pathways in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. S241–S245, 2003. View at Scopus
  15. Y. S. Kanwar, J. Wada, L. Sun et al., “Diabetic nephropathy: mechanisms of renal disease progression,” Experimental Biology and Medicine, vol. 233, no. 1, pp. 4–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. G. T. Mustata, M. Rosca, K. M. Biemel et al., “Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking,” Diabetes, vol. 54, no. 2, pp. 517–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. F. E. Mann, E. M. Lonn, Q. Yi et al., “Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE Study,” Kidney International, vol. 65, no. 4, pp. 1375–1380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Vignini, A. Alidori, L. Montesi et al., “Vitamin E, diabetes and related diseases: an update,” Mediterranean Journal of Nutrition and Metabolism, vol. 4, no. 1, pp. 3–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Jaffri, S. Mohamed, N. Rohimi, I. N. Ahmad, M. M. Noordin, and Y. A. Manap, “Antihypertensive and cardiovascular effects of catechin-rich oil palm (Elaeis guineensis) leaf extract in nitric oxide-deficient rats,” Journal of Medicinal Food, vol. 14, no. 7-8, pp. 775–783, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Khan and H. Mukhtar, “Tea polyphenols for health promotion,” Life Sciences, vol. 81, no. 7, pp. 519–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. T. Rosalina Tan, S. Mohamed, G. F. Samaneh, M. M. Noordin, Y. M. Goh, and M. Y. A. Manap, “Polyphenol rich oil palm leaves extract reduce hyperglycaemia and lipid oxidation in STZ-rats,” International Food Research Journal, vol. 18, no. 1, pp. 179–188, 2011. View at Scopus
  22. B. T. Doumas, D. D. Bayse, R. J. Carter, T. Peters Jr., and R. Schaffer, “A candidate Reference Method for determination of total protein in serum. I. Development and validation,” Clinical Chemistry, vol. 27, no. 10, pp. 1642–1650, 1981. View at Scopus
  23. M. Somogyi, “A method for the preparation of blood filtrates for the determination of sugar,” The Journal of Biological Chemistry, vol. 86, pp. 655–663, 1930.
  24. E. Bojesen, “A method for determination of inulin in plasma and urine,” Acta Medica Scandinavica. Supplementum, vol. 266, pp. 275–282, 1952. View at Scopus
  25. T. Saito, E. Sumithran, E. F. Glasgow, and R. C. Atkins, “The enhancement of aminonucleoside nephrosis by the co-administration of protamine,” Kidney International, vol. 32, no. 5, pp. 691–699, 1987. View at Scopus
  26. S. Taneda, J. W. Pippin, E. H. Sage et al., “Amelioration of diabetic nephropathy in SPARC-null mice,” Journal of the American Society of Nephrology, vol. 14, no. 4, pp. 968–980, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Runnie, N. M. Mustapha, R. Musec et al., “Antioxidant and hypercholesterolemic effects of Elaies guineensis fond extract on hypercholesterolemic rats,” ASEAN Food Journal, no. 3, pp. 137–148, 2003.
  28. J. M. Jaffri, S. Mohamed, I. N. Ahmad, N. M. Mustapha, Y. A. Manap, and N. Rohimi, “Effects of catechin-rich oil palm leaf extract on normal and hypertensive rats' kidney and liver,” Food Chemistry, vol. 128, no. 2, pp. 433–441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. H. Hostetter, J. L. Troy, and B. M. Brenner, “Glomerular hemodynamics in experimental diabetes mellitus,” Kidney International, vol. 19, no. 3, pp. 410–415, 1981. View at Scopus
  30. R. Veelken, K. F. Hilgers, A. Hartner, A. Haas, K. P. Böhmer, and R. B. Sterzel, “Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 71–79, 2000. View at Scopus
  31. R. Komers, T. J. Allen, and M. E. Cooper, “Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes,” Diabetes, vol. 43, no. 10, pp. 1190–1197, 1994. View at Scopus
  32. R. Komers, J. N. Lindsley, T. T. Oyama et al., “Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes,” The Journal of Clinical Investigation, vol. 107, no. 7, pp. 889–898, 2001. View at Scopus
  33. J. Li, Y. J. Chen, and J. Quilley, “Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat,” Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 2, pp. 818–824, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. J. Chen, J. Li, and J. Quilley, “Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat,” European Journal of Pharmacology, vol. 541, no. 1-2, pp. 80–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Koya, I. K. Lee, H. Ishii, H. Kanoh, and G. L. King, “Prevention of glomerullar dysfunction in diabetic rats by treatment with d-α-tocopherol,” Journal of the American Society of Nephrology, vol. 8, no. 3, pp. 426–435, 1997. View at Scopus
  36. M. F. Melhem, P. A. Craven, and F. R. DeRubertis, “Effects of dietary supplementation of α-Lipoic acid on early glomerular injury in diabetes mellitus,” Journal of the American Society of Nephrology, vol. 12, no. 1, pp. 124–133, 2001. View at Scopus
  37. J. Su, P. Zhang, J. J. Zhang, X. M. Qi, Y. G. Wu, and J. J. Shen, “Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats,” Phytomedicine, vol. 17, no. 3-4, pp. 254–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Satoh, S. Fujimoto, Y. Haruna et al., “NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy,” American Journal of Physiology, vol. 288, no. 6, pp. F1144–F1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, “Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy,” Diabetes, vol. 55, no. 1, pp. 225–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Kashihara, Y. Watanabe, H. Makino, E. I. Wallner, and Y. S. Kanwar, “Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 14, pp. 6309–6313, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Vink and B. R. Duling, “Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries,” Circulation Research, vol. 79, no. 3, pp. 581–589, 1996. View at Scopus
  42. F. R. DeRubertis, P. A. Craven, M. F. Melhem, and E. M. Salah, “Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide—nitric oxide interaction,” Diabetes, vol. 53, no. 3, pp. 762–768, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. R. F. Spurney and T. M. Coffman, “Stressed-out podocytes in diabetes?” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2035–2037, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Zheng, E. C. Carlson, L. Yang, P. M. Kralik, Y. Huang, and P. N. Epstein, “Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2077–2085, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Yamabe, T. Yokozawa, T. Oya, and M. Kim, “Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 1, pp. 228–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Bhatti, R. W. Mankhey, L. Asico, M. T. Quinn, W. J. Welch, and C. Maric, “Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney,” Kidney International, vol. 67, no. 4, pp. 1371–1380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. H. A. H. Kataya and A. A. Hamza, “Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 3, pp. 281–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. R. M. Mason and N. A. Wahab, “Extracellular matrix metabolism in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1358–1373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. P. A. Craven, F. R. Derubertis, V. E. Kagan, M. Melhem, and R. K. Studer, “Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes,” Journal of the American Society of Nephrology, vol. 8, no. 9, pp. 1405–1414, 1997. View at Scopus
  50. H. Ha and Hi Bahl Lee, “Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose,” Kidney International, Supplement, vol. 58, no. 77, pp. S19–S25, 2000. View at Scopus
  51. M. C. Iglesias-De La Cruz, P. Ruiz-Torres, J. Alcamí et al., “Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells,” Kidney International, vol. 59, no. 1, pp. 87–95, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. R. K. Studer, P. A. Craven, and F. R. DeRubertis, “Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells,” Metabolism, vol. 46, no. 8, pp. 918–925, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Ha, S. H. Lee, and K. H. Kim, “Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-β and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 281, no. 3, pp. 1457–1462, 1997. View at Scopus
  54. E. B. M. I. Peixoto, B. S. Pessoa, S. K. Biswas, and J. B. Lopes De Faria, “Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension,” American Journal of Nephrology, vol. 29, no. 4, pp. 309–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Li, F. Wang, L. Zhang et al., “Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells,” Cellular Signalling, vol. 23, no. 10, pp. 1625–1632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Ha and K. H. Kim, “Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C,” Diabetes Research and Clinical Practice, vol. 45, no. 2-3, pp. 147–151, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. I. G. Obrosova, L. Fathallah, E. Liu, and J. Nourooz-Zadeh, “Early oxidative stress in the diabetic kidney: effect of DL-α-lipoic acid,” Free Radical Biology and Medicine, vol. 34, no. 2, pp. 186–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. K. I. Sugimoto, S. Tsuruoka, and A. Fujimura, “Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties,” Clinical and Experimental Pharmacology and Physiology, vol. 28, no. 10, pp. 826–830, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. P. S. Van Dam, B. Bravenboer, B. S. Van Asbeck, J. F. L. M. Van Oirschot, J. J. M. Marx, and W. H. Gispen, “Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozotocin-diabetic rats,” European The Journal of Clinical Investigation, vol. 26, no. 12, pp. 1143–1149, 1996. View at Scopus
  60. M. Kakimoto, T. Inoguchi, T. Sonta et al., “Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats,” Diabetes, vol. 51, no. 5, pp. 1588–1595, 2002. View at Scopus